COM(2018)159 EU - Report
Delegation of power under Regulation 273/2004 on drug precursors and Council Regulation (EC) No 111/2005 on the monitoring of trade with third countries in drug precursors - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
official title
REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the delegation of power under Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third countries in drug precursors| Legal instrument | Report |
|---|---|
| reference by COM-number i | COM(2018)159  |
| CELEX number i | 52018DC0159 |
| Document | 27-03-2018 |
|---|---|
| Online publication | 27-03-2018 |
This page is also available in a full version containing the legal context, other dossiers related to the dossier at hand, the stakeholders involved (e.g. European Commission directorates-general, European Parliament committees, Council configurations and even individual EU Commissioners and Members of the European Parliament) and documents of the European Parliament, the Council of Ministers and the European Commission.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.